RedHill Biopharma   Report issue

For profit Phase 2 Phase 3
Founded: Tel Aviv Israel (2009)

Organization Overview

First Clinical Trial
2011
NCT01488513
First Marketed Drug
2014
naloxegol (movantik)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

REDHILL | RedHill Biopharma, Inc. | RedHill Biopharma Limited | RedHill Biopharma Ltd. | REDHILL BIOPHARMA LTD